+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sanger Sequencers Market - Global Forecast 2026-2032- Product Image
Sanger Sequencers Market - Global Forecast 2026-2032- Product Image
Sale

Sanger Sequencers Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122777
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sanger Sequencers Market is projected to reach USD 603.59 Million in 2026. It is expected to continue growing at a CAGR of 6.65%, reaching USD 874.84 Million by 2032.

Sanger Sequencers Support High-Confidence Genetic Analysis

Sanger sequencing remains a targeted method for confirming variants, characterizing amplicons, validating constructs, and resolving sequence questions where accuracy and interpretability are priorities. Its role is complementary to high-throughput sequencing, particularly when laboratories need focused analysis, established workflows, and results that can be readily reviewed by experienced personnel.

Workflow Integration Is Reshaping Sanger Sequencing

The landscape is shifting from standalone instruments toward integrated laboratory workflows that connect sample preparation, sequencing, capillary operation, data analysis, quality control, and reporting. Laboratories are also placing greater emphasis on automation, standardized protocols, service support, instrument uptime, and compatibility with existing molecular diagnostics and research infrastructure.

Artificial Intelligence Strengthens Interpretation and Operations

Artificial intelligence can improve Sanger sequencing workflows by assisting with chromatogram quality assessment, peak interpretation, variant review, contamination screening, and exception handling. Its most practical near-term contribution is decision support rather than replacement of laboratory expertise. Effective adoption requires validated training data, transparent review processes, auditability, and human confirmation for clinically or scientifically consequential findings.

Regional Conditions Shape Adoption and Workflow Design

North America benefits from mature genomics infrastructure, specialized laboratories, and strong demand for confirmatory testing. Europe combines advanced research capacity with varied national procurement and regulatory environments. Asia-Pacific is characterized by expanding molecular biology capabilities and uneven access to advanced laboratory services. Latin America is developing sequencing capacity while navigating equipment access, workforce availability, and supply-chain complexity. The Middle East is investing in genomics programs and centralized laboratory capabilities, whereas Africa faces greater variation in infrastructure, funding, technical training, and sample logistics. Across all regions, local validation, service coverage, data governance, and dependable consumables supply are important adoption considerations.

Economic and Institutional Groups Create Distinct Operating Contexts

ASEAN laboratories often balance expanding biomedical capacity with differences in infrastructure and technical resources across member states. BRICS countries span substantial variation in research ecosystems, public-health priorities, and domestic manufacturing capabilities. The European Union emphasizes harmonized quality, data protection, and cross-border research within a diverse procurement environment. G7 members generally operate mature laboratory networks with strong expectations for validation and interoperability. GCC countries are building centralized and specialized genomics capabilities, while NATO members reflect varied national systems but share interest in resilient biomedical supply chains, research collaboration, and laboratory preparedness.

Country-Level Priorities Vary Across Established and Emerging Systems

Australia combines advanced research infrastructure with geographic considerations affecting service delivery. Brazil and Mexico are expanding molecular testing capacity while addressing regional disparities in laboratory resources. Canada and the United States have sophisticated research and diagnostic ecosystems with strong requirements for quality assurance and workflow integration. China, India, Japan, and South Korea combine substantial scientific capabilities with differing regulatory, procurement, and domestic-production environments. France, Germany, Italy, Spain, and the United Kingdom maintain established genomics and biomedical research networks, with attention to laboratory standards, data governance, and healthcare integration. Russia has significant scientific expertise alongside distinct procurement and infrastructure considerations.

Leaders Should Prioritize Validated, Connected, and Resilient Workflows

Industry leaders should define Sanger sequencing use cases around confirmation, targeted characterization, and quality control rather than treating the method as a universal substitute for high-throughput sequencing. They should prioritize interoperability with laboratory information systems, clear quality metrics, automation where it reduces manual error, and software that supports transparent review. Regional service networks, training, preventive maintenance, consumables resilience, and documented cybersecurity practices can improve continuity. Artificial intelligence should be introduced through controlled validation, role-based oversight, and monitoring for interpretation errors or model drift.

Methodology Combines Structured Review With Cross-Regional Interpretation

This executive summary is based on a structured assessment of the Sanger sequencer landscape, including workflow roles, laboratory requirements, technology integration, artificial-intelligence applications, and geographic operating conditions. Regional, group, and country perspectives were organized around infrastructure maturity, research and diagnostic use, regulation, workforce, procurement, interoperability, and supply-chain considerations. Claims were limited to broadly supportable qualitative findings, and no market estimates, forecasts, company comparisons, or market-share assessments were used.

Sanger Sequencing Retains a Focused Role in Modern Genomics

Sanger sequencing continues to provide value where targeted, high-confidence sequence confirmation and understandable evidence are essential. Its future position will depend less on instrument capability alone and more on connected workflows, dependable support, rigorous quality systems, and responsible use of automation and artificial intelligence. Laboratories that align the method with clearly defined analytical needs can preserve its strengths while integrating it effectively with broader genomic testing strategies.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sanger Sequencers Market, by Product Type
7.1. Introduction
7.2. Consumables & Reagents
7.2.1. Capillaries & Plates
7.2.2. Sequencing Kits
7.3. Instruments
7.3.1. Capillary Electrophoresis Systems
7.3.2. Gel-Based Sequencers
7.4. Services
8. Sanger Sequencers Market, by Workflow Step
8.1. Introduction
8.2. Data Analysis
8.2.1. Alignment
8.2.2. Data Interpretation
8.2.3. Variant Calling
8.3. Sample Preparation
8.3.1. DNA Extraction
8.3.2. Purification & QC
8.4. Sequencing & Data Acquisition
8.4.1. Capillary Electrophoresis
8.4.2. Detection Technologies
9. Sanger Sequencers Market, by Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Clinical Diagnostics
9.2.2. Oncology Diagnostics
9.2.3. Prenatal Diagnostics
9.3. Genetic Research
9.3.1. Mendelian Research
9.3.2. Population Genetics
9.4. Pharmaceutical R&D
9.4.1. Drug Discovery
9.4.2. Pharmacogenomics
10. Sanger Sequencers Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Research Centers
10.2.2. Universities
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.4.1. Clinical Research Units
10.4.2. Diagnostic Laboratories
10.5. Pharmaceutical & Biotechnology Companies
10.5.1. Biotech Companies
10.5.2. Pharmaceutical Companies
11. Sanger Sequencers Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Sanger Sequencers Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Sanger Sequencers Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 10x Genomics, Inc.
15.2. Agilent Technologies, Inc.
15.3. BGI Group
15.4. Bio-Rad Laboratories, Inc.
15.5. Eurofins Scientific
15.6. Genewiz, Inc.
15.7. GenScript Biotech Corporation
15.8. Illumina, Inc.
15.9. Macrogen, Inc.
15.10. MGI Tech Co., Ltd.
15.11. Oxford Nanopore Technologies Ltd.
15.12. Pacific Biosciences of California, Inc.
15.13. PerkinElmer, Inc.
15.14. QIAGEN N.V.
15.15. Roche Holding AG
15.16. Standard BioTools, Inc.
15.17. Takara Bio, Inc.
15.18. Thermo Fisher Scientific, Inc.
15.19. Waters Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sanger Sequencers Market, Years Considered for the Study
FIGURE 2. Global Sanger Sequencers Market, Research Design
FIGURE 3. Global Sanger Sequencers Market, Research Framework
FIGURE 4. Global Sanger Sequencers Market, Data Triangulation
FIGURE 5. Global Sanger Sequencers Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sanger Sequencers Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Sanger Sequencers Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sanger Sequencers Market Size, by Workflow Step, 2025 vs 2032 (%)
FIGURE 9. Global Sanger Sequencers Market Size, by Workflow Step, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sanger Sequencers Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Sanger Sequencers Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sanger Sequencers Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Sanger Sequencers Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sanger Sequencers Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Sanger Sequencers Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Sanger Sequencers Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Sanger Sequencers Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Sanger Sequencers Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Sanger Sequencers Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sanger Sequencers Market Segmentation & Coverage
TABLE 2. Global Sanger Sequencers Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Capillaries & Plates Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Capillaries & Plates Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Capillaries & Plates Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sequencing Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sequencing Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sequencing Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Capillary Electrophoresis Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Capillary Electrophoresis Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Capillary Electrophoresis Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Gel-Based Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Gel-Based Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Gel-Based Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 26. Global Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Alignment Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Alignment Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Alignment Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Data Interpretation Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Data Interpretation Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Data Interpretation Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Variant Calling Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Variant Calling Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Variant Calling Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Sample Preparation Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Sample Preparation Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Sample Preparation Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global DNA Extraction Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global DNA Extraction Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global DNA Extraction Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Purification & QC Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Purification & QC Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Purification & QC Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Sequencing & Data Acquisition Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Sequencing & Data Acquisition Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Sequencing & Data Acquisition Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Capillary Electrophoresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Capillary Electrophoresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Capillary Electrophoresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Detection Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Detection Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Detection Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Oncology Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Oncology Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Oncology Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Prenatal Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Prenatal Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Prenatal Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Genetic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Genetic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Genetic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Mendelian Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Mendelian Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Mendelian Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Population Genetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Population Genetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Population Genetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Pharmaceutical R&D Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Pharmaceutical R&D Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Pharmaceutical R&D Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Government Research Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Government Research Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Government Research Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Clinical Research Units Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Clinical Research Units Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Clinical Research Units Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 135. North America Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. North America Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. North America Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 138. North America Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 139. North America Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 140. North America Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 141. North America Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 142. North America Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 143. North America Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. North America Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 145. North America Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 146. North America Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 147. North America Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. North America Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 149. North America Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 150. North America Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 151. Latin America Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Latin America Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. Latin America Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 154. Latin America Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 155. Latin America Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 156. Latin America Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 157. Latin America Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 158. Latin America Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 159. Latin America Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Latin America Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 161. Latin America Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 162. Latin America Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 163. Latin America Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Latin America Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 165. Latin America Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 166. Latin America Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 167. Europe Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Europe Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Europe Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 170. Europe Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 171. Europe Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 172. Europe Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 173. Europe Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 174. Europe Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 175. Europe Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Europe Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 177. Europe Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 178. Europe Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 179. Europe Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Europe Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 181. Europe Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 182. Europe Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 183. Middle East Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Middle East Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. Middle East Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 186. Middle East Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 187. Middle East Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 188. Middle East Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 189. Middle East Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 190. Middle East Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 191. Middle East Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Middle East Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 193. Middle East Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 194. Middle East Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 195. Middle East Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Middle East Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 197. Middle East Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 198. Middle East Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 199. Africa Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Africa Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. Africa Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 202. Africa Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 203. Africa Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 204. Africa Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 205. Africa Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 206. Africa Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 207. Africa Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Africa Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 209. Africa Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 210. Africa Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 211. Africa Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Africa Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 213. Africa Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 214. Africa Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 215. Global Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. ASEAN Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. ASEAN Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. ASEAN Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 219. ASEAN Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 220. ASEAN Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 221. ASEAN Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 222. ASEAN Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 223. ASEAN Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 224. ASEAN Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. ASEAN Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 226. ASEAN Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 227. ASEAN Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 228. ASEAN Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. ASEAN Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 230. ASEAN Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 231. ASEAN Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 232. GCC Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. GCC Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. GCC Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 235. GCC Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 236. GCC Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 237. GCC Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 238. GCC Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 239. GCC Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 240. GCC Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. GCC Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 242. GCC Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 243. GCC Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 244. GCC Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. GCC Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 246. GCC Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 247. GCC Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 248. European Union Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. European Union Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. European Union Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 251. European Union Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 252. European Union Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 253. European Union Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 254. European Union Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 255. European Union Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 256. European Union Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. European Union Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 258. European Union Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 259. European Union Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 260. European Union Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. European Union Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 262. European Union Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 263. European Union Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 264. BRICS Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 265. BRICS Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. BRICS Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 267. BRICS Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 268. BRICS Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 269. BRICS Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 270. BRICS Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 271. BRICS Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 272. BRICS Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. BRICS Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 274. BRICS Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 275. BRICS Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 276. BRICS Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. BRICS Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 278. BRICS Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 279. BRICS Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 280. G7 Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 281. G7 Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 282. G7 Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 283. G7 Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 284. G7 Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 285. G7 Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 286. G7 Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 287. G7 Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 288. G7 Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. G7 Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 290. G7 Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 291. G7 Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 292. G7 Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. G7 Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 294. G7 Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 295. G7 Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 296. NATO Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. NATO Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. NATO Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 299. NATO Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 300. NATO Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 301. NATO Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 302. NATO Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 303. NATO Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 304. NATO Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. NATO Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 306. NATO Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 307. NATO Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 308. NATO Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. NATO Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 310. NATO Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 311. NATO Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 312. Global Sanger Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 313. United States Sanger Sequencers Market Size, 2017-2032 (USD Million)
TABLE 314. United States Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. United States Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 316. United States Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 317. United States Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 318. United States Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 319. United States Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 320. United States Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 321. United States Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 322. United States Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 323. United States Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 324. United States Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 325. United States Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. United States Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 327. United States Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 328. United States Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 329. Canada Sanger Sequencers Market Size, 2017-2032 (USD Million)
TABLE 330. Canada Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 331. Canada Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 332. Canada Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 333. Canada Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 334. Canada Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 335. Canada Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 336. Canada Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-2032 (USD Million)
TABLE 337. Canada Sanger Sequencers Market Size, by Application, 2017-2032 (USD Million)
TABLE 338. Canada Sanger Sequencers Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 339. Canada Sanger Sequencers Market Size, by Genetic Research, 2017-2032 (USD Million)
TABLE 340. Canada Sanger Sequencers Market Size, by Pharmaceutical R&D, 2017-2032 (USD Million)
TABLE 341. Canada Sanger Sequencers Market Size, by End User, 2017-2032 (USD Million)
TABLE 342. Canada Sanger Sequencers Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 343. Canada Sanger Sequencers Market Size, by Hospitals & Clinics, 2017-2032 (USD Million)
TABLE 344. Canada Sanger Sequencers Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 345. Mexico Sanger Sequencers Market Size, 2017-2032 (USD Million)
TABLE 346. Mexico Sanger Sequencers Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 347. Mexico Sanger Sequencers Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 348. Mexico Sanger Sequencers Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 349. Mexico Sanger Sequencers Market Size, by Workflow Step, 2017-2032 (USD Million)
TABLE 350. Mexico Sanger Sequencers Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 351. Mexico Sanger Sequencers Market Size, by Sample Preparation, 2017-2032 (USD Million)
TABLE 352. Mexico Sanger Sequencers Market Size, by Sequencing & Data Acquisition, 2017-

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • Genewiz, Inc.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • Standard BioTools, Inc.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

Related Topics

Related Reports

DNA Sequencer Market - Global Forecast 2026-2032 - Product Image

DNA Sequencer Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
DNA Sequencing Machine Market - Global Forecast 2026-2032 - Product Image

DNA Sequencing Machine Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Gene Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Gene Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Rare Disease Genetic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Rare Disease Genetic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
DNA Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

DNA Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.